EMAIL THIS PAGE TO A FRIEND

Biomaterials

Doxorubicin-loaded polysaccharide nanoparticles suppress the growth of murine colorectal carcinoma and inhibit the metastasis of murine mammary carcinoma in rodent models.


PMID 25771007

Abstract

As a synergistic drug combination, doxorubicin-loaded cisplatin crosslinked polysaccharide-based nanoparticles (Dex-SA-DOX-CDDP) have demonstrated enhanced antitumor efficacy and reduced systemic toxicity via optimized biodistribution, controlled drug release, prolonged blood circulation, and improved tolerability, compared to the non-crosslinked nanoparticles or free doxorubicin. Herein, we apply the Dex-SA-DOX-CDDP nanoparticles as an efficient antitumor agent to treat colorectal and breast tumors in three different in vivo models, i.e. subcutaneously implanted colorectal carcinoma, dimethylhydrazine-induced autochthonous colorectal carcinoma, and metastatic mammary carcinoma, which more closely simulate the natural milieu of the original tumor with intact pathological and immunological responses. Based on the properties of this combination in higher tumor accumulation and penetrating efficiency, the Dex-SA-DOX-CDDP nanoparticles significantly decreased the tumor sizes in CT26 cell line xenograft tumors compared to control. In addition, the affected animals' lifespan was significantly extended after the Dex-SA-DOX-CDDP treatment, in the autochthonous colon cancer model. Moreover, with the aid of iRGD, Dex-SA-DOX-CDDP could effectively block primary tumor growth and prevent the metastasis of 4T1 murine mammary carcinoma. In conclusion, Dex-SA-DOX-CDDP nanoparticles remarkably inhibit growth of colorectal carcinoma and metastasis of mammary carcinoma in vivo, which provides potential application as a safe and efficient antitumor agent in treatment of these cancers.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

D8417
4′,6-Diamidino-2-phenylindole dihydrochloride, powder, BioReagent, suitable for cell culture, ≥98% (HPLC and TLC), suitable for fluorescence
C16H15N5 · 2HCl
32670
4′,6-Diamidino-2-phenylindole dihydrochloride, suitable for fluorescence, BioReagent, ≥95.0% (HPLC)
C16H15N5 · 2HCl
D161403
5,5-Dimethylhydantoin, 97%
C5H8N2O2
E5134
Ethylenediaminetetraacetic acid disodium salt dihydrate, for electrophoresis, for molecular biology, 99.0-101.0% (titration)
C10H14N2Na2O8 · 2H2O
E1644
Ethylenediaminetetraacetic acid disodium salt dihydrate, BioUltra, 98.5-101.5%
C10H14N2Na2O8 · 2H2O
E6635
Ethylenediaminetetraacetic acid disodium salt dihydrate, Sigma Grade, plant cell culture tested, 98.5-101.5%
C10H14N2Na2O8 · 2H2O
E5513
Ethylenediaminetetraacetic acid disodium salt dihydrate, for electrophoresis, 98.5-101.5%
C10H14N2Na2O8 · 2H2O
E4884
Ethylenediaminetetraacetic acid disodium salt dihydrate, ACS reagent, 99.0-101.0%
C10H14N2Na2O8 · 2H2O
ED2SS
Ethylenediaminetetraacetic acid disodium salt dihydrate, reagent grade, 98.5-101.5% (titration)
C10H14N2Na2O8 · 2H2O
03677
Ethylenediaminetetraacetic acid disodium salt dihydrate, BioUltra, for molecular biology, ≥99.0% (T)
C10H14N2Na2O8 · 2H2O
27285
Ethylenediaminetetraacetic acid disodium salt dihydrate, meets analytical specification of Ph. Eur., BP, USP, FCC, 99.0-101.0%
C10H14N2Na2O8 · 2H2O
03685
Ethylenediaminetetraacetic acid disodium salt dihydrate, ≥97.0% (KT)
C10H14N2Na2O8 · 2H2O
2854
Ethylenediaminetetraacetic acid disodium salt solution, 2%, solution
C10H14N2Na2O8
E7889
Ethylenediaminetetraacetic acid disodium salt solution, for molecular biology, 0.5 M in H2O, DNase, RNase, NICKase and protease, none detected
C10H14N2Na2O8
D161608
N,N-Dimethylhydrazine, 98%
C2H8N2